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ABSTRACT 
A series of substituted 1,4-dihydopyridine derivatives (SC1-SC10) was synthesized via condensation of acetoacetanilide /4-chloro 
acetoacetanilide and substituted benzaldehyde in methanol with excess amount of ammonia. The synthesized compounds were 
characterized using FT-IR, NMR and Mass spectroscopic techniques.The anti-bacterial and anti-fungal activity of title compounds 
was evaluated utilizing paper disc diffusion method. The anti-bacterial activity was determined by using S. aureus and E.coli as the 
gram-positive and gram negative strains, while Candida albicans was used to evaluate the anti-fungal activity of synthesized 
compounds. 1,4-dihydropyridine derivative (SC8) with bromo group at para position of phenyl ring attached to dihydropyridine ring 
and chloro group linked to para position of carbamoyl phenyl ring was found to be the most active anti-bacterial agent, with its 
activity observed more on gram negative strain (81.76%) as compared to gram positive strain (75.94%). The most active anti-fungal 
agent was found to be SC1 (86.85%); 1,4-dihydropyridine derivative with hydroxy group at 2nd position and bromo group at 5th 
position of phenyl ring attached to dihydropyridine ring while chloro group linked to para position of carbamoyl phenyl ring. This 
suggests the requirement of electron withdrawing group at 3rd and 5th position of dihydropyridine ring for anti-bacterial and anti-
fungal activity. 
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INTRODUCTION: 
1, 4 Dihydropyridines are nitrogen containing 
heterocyclic compounds with nitrogen as the hetero-
atom. This nucleus is associated with varied 
pharmacological activities, viz. anti-microbial, anti-
tubercular, anti-cancer, antioxidant, vasodilator, calcium 
channel blocker, analgesic, anticonvulsant, anti-
inflammatory, anti-ulcer activities
1
. Extensive literature 
survey revealed its potential for antimicrobial activity. 
The present work was thus focused to explore the anti-
microbial activity of this nucleus. In this regard, it was 
planned to synthesize a series of 1,4dihydropyridine 
derivatives (Table 1) by utilizing different substituted 
aromatic aldehydes group with acetoacetanilide in 
presence of ammonia and methanol. 
MATERIAL AND METHODS: 
Synthesis A mixture of acetoacetanilide /4-chloro 
acetoacetanilide (0.02 mol) and substituted 
benzaldehyde (0.01 mol) was dissolved in methanol. 5-7 
ml of ammonia (25%) solution was added, followed by 
refluxing for 5–6 h (Scheme 1). 2-3 ml ammonia was 
added at an interval of 3-4 h and the refluxing was 
continued for 24 h
2-3
. The reaction mixture was kept 
overnight and the crystalline product was separated out. 
It was then filtered, washed 2–3 times with chilled 
methanol, dried and recrystallized using methanol. The 
synthesized compounds were characterized using FT-IR, 
NMR and Mass spectroscopic techniques. 
Anti-bacterial activity assay The cultures of gram 
positive and gram negative strains were obtained in 
Mueller–Hinton Broth after incubating them at 37 ± 1C 
for 18–24 h. The anti-bacterial activity was performed 
on Mueller–Hinton Broth at pH 7.4 and twofold dilution 
technique was applied. The growth of microorganism 
was recorded to inhibition zone diameter expressed in 
percent of relative inhibition zone diameter after 
incubation for 18–24 h at 37 ± 1C. Ciprofloxacin was 
used as standard.  
Anti-fungal activity assay The yeasts were maintained 
in Sabouraud Dextrose Broth pH 7.4 after incubation for 
48 h at 25 ± 1C. Controls tubes contained only 
inoculated broth. The growth of microorganism was 
recorded to inhibition zone diameter expressed in 
percent of relative inhibition zone diameter after 
incubation for 48 h at 37 ± 1C. Fluconazole was used as 
standard drug. 
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Table 1: Substituted 1, 4 dihydropyridine derivatives 
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Comp. Code R R1 
SC1 2-OH, 5-Br 4-Cl 
SC2 4-OH H 
SC3 3,4,5-trimethoxy H 
SC4 2-NO2 4-Cl 
SC5 3,4-dimethoxy 4-Cl 
SC6 2-NO2 H 
SC7 3,4-dimethoxy H 
SC8 4-Br 4-Cl 
SC9 4-NO2 4-Cl 
SC10 4-NO2 H 
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1, 4-dihydropyridine derivatives 
Scheme 1: Synthesis of 1, 4-dihydropyridines derivatives 
Calculation of percent of relative inhibition zone 
diameter The percent of relative inhibition zone 
diameter (% RIZD) is the calculation of percentage of 
relative inhibition zone obtained for control as compared 
to zone of inhibition obtained from standard drug at 
same concentration. The antimicrobial activity was 
calculated by applying the expression: 
% RIZD =  
                                 
                                   
  X 100% 
where RIZD is the percent of relative inhibition zone 
and IZD is the inhibition zone diameter (mm). 
RESULTS AND DISCUSSION: 
The title compounds were synthesized via condensation 
of acetoacetanilide /4-chloro acetoacetanilide and 
substituted benzaldehyde in methanol. These newly 
synthesized compounds were assayed for their 
antimicrobial activity against Staphylococcus aureus 
(Gram-positive bacteria) and Escherichia coli (Gram 
negative bacteria) and the fungal strain Candida 
albicans. The antibacterial activity of compounds was 
determined by the paper disc diffusion method using 
Mueller-Hinton agar. Ciprofloxacin was used as the 
reference antibacterial agent.  The antifungal activity of 
compounds was determined by the paper disc diffusion 
method using Sabouraud dextrose agar growth medium. 
Fluconazole was used as the reference antifungal agent. 
All synthesized compounds exhibited higher inhibitory 
activity against gram negative bacteria than gram 
positive bacteria (Table 2, Fig.1). 
Staphylococcus aureus (gram positive) All the 
compounds were inactive towards S. aureus at minimum 
concentration of 6.25 μg/ml whereas the compounds 
showed a significant inhibitory activity towards S. 
aureusat concentration ranging from 12.5-50 μg/ml. 
Compound SC8 exhibited highest inhibitory activity. 
Following is the antibacterial efficacy of synthesized 
compounds against S.aureus in decreasing order –  
SC8 > SC1 > SC7 > SC10 > SC6 > SC3 > SC4 > SC9 > SC2 > SC5 
E. coli (gram negative) All the compounds were inactive 
towards E. coli at minimum concentration of 6.25 μg/ml 
whereas the compounds showed a significant inhibitory 
activity towards E. coli at concentration range12.5, 25, 
50,100 μg/ml, amongst all these compounds, SC8 
(81.76%) showed highest percentage of relative zone of 
inhibition.  Following is the antibacterial efficacy of 
synthesized compounds against E. coli in decreasing 
order  
SC8 > SC3 > SC4 > SC10 > SC9 > SC5 > SC1 > SC2 > SC6 > SC7 
Candida albicans (fungi) all the compounds were 
inactive towards C. albicansat minimum concentration 
of 6.25 μg/ml and 12.5 μg/ml.  Whereas the compounds 
showed a significant inhibitory activity towards C. 
albicansat concentration range 25, 50,100 μg/ml. 
Amongst all these compounds, SC1 (86.85%) exhibited 
highest percentage of relative zone of inhibition (Table 
3, Figure 1). 
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Table 2: Anti-bacterial activity of synthesized 1,4-dihydropyridine derivatives in terms of RIZD 
Bact.strain Escherichia coli Staphylococcus aureus  
Conc. in 
(µg/ml) 
6.25 12.5 25 50 100 6.25 12.5 25 50 100 
Comp. no. Relative inhibition  zone diameter in percentage  
SC1 - 75.15 79.37 80.05 75.45 - 75.00 71.76 71.85 73.04 
SC2 - 74.33 73.76 75.79 71.97 - 71.81 66.64 65.45 64.38 
SC3 - 80.49 81.05 80.51 75.05 - 72.44 67.59 65.94 69.15 
SC4 - 79.73 74.66 75.09 77.51 - 72.16 70.87 67.79 67.33 
SC5 - 77.44 74.94 75.79 74.35 - 71.12 67.36 67.52 68.22 
SC6 - 74.20 78.02 74.70 73.69 - 73.83 67.30 67.21 65.46 
SC7 - 70.64 80.54 75.34 75.00 - 74.93 66.46 68.79 65.07 
SC8 - 81.76 76.34 78.42 71.22 - 75.94 66.34 65.62 67.87 
SC9 - 77.70 76.45 76.04 74.57 - 71.88 69.62 67.74 73.33 
SC10 - 78.65 80.66 83.58 77.51 - 74.39 68.25 65.83 64.58 
 
Table 3:  Anti-fungal activity of synthesized 1,4-dihydropyridine derivatives in terms of RIZD 
Fungal strain  Candida albicans  
Conc. in (µg/ml) 6.25 12.5 25 50 100 
Comp. No. Relative inhibition  zone diameter in percentage 
SC1 - - 86.85 78.63 79.53 
SC2 - - 74.98 77.27 78.62 
SC3 - - 79.31 78.38 75.85 
SC4 - - 82.82 84.57 82.76 
SC5 - - 81.70 80.15 75.56 
SC6 - - 76.92 79.77 76.30 
SC7 - - 80.58 76.61 77.38 
SC8 - - 75.35 79.73 78.00 
SC9 - - 74.98 77.37 78.62 
  SC10 - - 82.00 79.77 76.36 
 
Following is the antimicrobial efficacy of synthesized compounds against C. albicans in decreasing order:  SC1 > SC4 
> SC10 > SC5 > SC7 > SC3 > SC8 > SC2, SC9 
           
(A)                                                                 (B) 
 
(C) 
Figure 1: Antimicrobial activity of synthesized compounds against (A) S. aureus (B) E. coli (C) C. albicans 
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CONCLUSION: 
1,4-dihydropyridine derivative (SC8) with bromo group 
at para position of phenyl ring attached to 
dihydropyridine ring and chloro group linked to para 
position of carbamoyl phenyl ring was found to be the 
most active anti-bacterial agent, with its activity 
observed more on gram negative strain (81.76%) as 
compared to gram positive strain (75.94%). The most 
active anti-fungal agent was found to be SC1 (86.85%); 
1,4-dihydropyridine derivative with hydroxy group at 2
nd
 
position and bromo group at 5
th
 position of phenyl ring 
attached to dihydropyridine ring while chloro group 
linked to para position of carbamoyl phenyl ring. This 
suggests the requirement of electron withdrawing group 
at 3
rd
 and 5
th
 position of dihydropyridine ring for anti-
bacterial and anti-fungal activity. 
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